[1]
Szmit , S., Jędrzejczak , W.W. and Opolski , G. 2013. Consensus statement on indications for the use of non-pegylated liposomal doxorubicin in patients with lymphomas and concomitant cardiovascular diseases. OncoReview. 3, 3(11) (Oct. 2013), 213-215.